• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Neogenomics Inc (NQ: NEO )

    13.73 UNCHANGED
    Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 257,724
    Open 13.76
    Bid (Size) 13.57 (20)
    Ask (Size) 14.75 (2)
    Prev. Close 13.73
    Today's Range 13.58 - 13.79
    52wk Range 11.03 - 21.22
    Shares Outstanding 122,816,314
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Fort Myers’ Mayor to Proclaim June as NeoGenomics’ Commitment to Cancer Month
    From NeoGenomics, Inc.
    Via Business Wire
    NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management
    From NeoGenomics, Inc.
    Via Business Wire

    Performance

    YTD
    -13.92%
    -13.92%
    1 Month
    +1.55%
    +1.55%
    3 Month
    -7.29%
    -7.29%
    6 Month
    -13.92%
    -13.92%
    1 Year
    -12.99%
    -12.99%

    More News

    Read More
    NeoGenomics Earnings Analysis: Q1 Recap
    Via Benzinga
    Where NeoGenomics Stands With Analysts
    Via Benzinga
    What 6 Analyst Ratings Have To Say About NeoGenomics
    Via Benzinga
    Evaluating NeoGenomics: Insights From 4 Financial Analysts
    Via Benzinga
    Recap: NeoGenomics Q4 Earnings
    Via Benzinga
    NEO Stock Earnings: NeoGenomics Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    NeoGenomics Reports First Quarter 2024 Results
    From NeoGenomics, Inc.
    Via Business Wire
    NeoGenomics Announces Senior Leadership Promotions
    From NeoGenomics, Inc.
    Via Business Wire
    NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024
    From NeoGenomics, Inc.
    Via Business Wire
    NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting
    From NeoGenomics, Inc.
    Via Business Wire
    NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report
    From NeoGenomics, Inc.
    Via Business Wire
    Earnings Scheduled For March 15, 2024
    Via Benzinga
    NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference
    From NeoGenomics, Inc.
    Via Business Wire
    Goldman Sachs Maintains Buy Rating for NeoGenomics: Here's What You Need To Know
    Via Benzinga
    NeoGenomics Stock Surged But Technicals Point To A Pullback
    Via Talk Markets
    Why Is Cancer Genetics Test-Focused NeoGenomics Stock Trading Higher Today?
    Via Benzinga
    Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Why NeoGenomics Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    NeoGenomics Reports Fourth Quarter and Full Year 2023 Results
    From NeoGenomics, Inc.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.